Sex Differences in the Cancer Proteome
Preprint
Abstract
Proteins play a central role in cancer biology: they are the most common drug targets and biomarkers. Sex influences the proteome in many diseases, ranging from neurological to cardiovascular. In cancer, sex is associated with incidence, progression and therapeutic response, as well as characteristics of the tumour genome and transcriptome. The extent to which sex differences impact the cancer proteome remains largely unknown. To fill this gap, we quantified sex differences across 1,590 proteomes from eight cancer types, identifying 901 genes with sex-differential proteins abundance in adenocarcinomas of the lung, and 20 genes across five other tumour types: squamous cell carcinoma of the lung, hepatocellular carcinomas, clear cell cancers of the kidney, adenocarcinomas of the pancreas and glioblastoma. A subset of these protein differences could be rationalized by sex-differential copy number aberrations. Pathway analysis showed that male-biased proteins in lung adenocarcinoma were enriched in MYC and E2F target pathways. These findings highlight the modest impact of sex on the cancer proteome, but the very limited power of existing proteomics cohorts for these analyses.Keywords
This publication has 44 references indexed in Scilit:
- Proteogenomic characterization of pancreatic ductal adenocarcinomaCell, 2021
- A proteogenomic portrait of lung squamous cell carcinomaCell, 2021
- Proteogenomic and metabolomic characterization of human glioblastomaCancer Cell, 2021
- Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinomaCancer Cell, 2021
- Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung AdenocarcinomaCell, 2020
- PFKP is highly expressed in lung cancer and regulates glucose metabolismCellular Oncology, 2020
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell CarcinomaCell, 2019
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular CarcinomaCell, 2019
- Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic OpportunitiesCell, 2019
- Trends in Presentation and Survival for Gallbladder Cancer During a Period of More Than 4 DecadesArchives of Surgery, 2009